05.14.14
The Tempus Pro has passed a major field test.
The U.S. Food and Drug Administration-cleared telemedicine device from Remote Diagnostic Technologies Limited underwent two days of informational and operational testing in Camp Pendleton, Calif., earlier this year. The Tempus Pro attaches to the patient at the point of injury and broadcasts vital signs back to a battalion aid station or aiding physician who in turn, helps field soldiers diagnose and treat battlefield injuries.
Lt. Cmdr. David Gribben, project head of expeditionary medicine with Marine Corps War Fighting Lab (MCWL), said the brief field trial allowed military officials to test the device in a controlled setting to determine future options for the product.
“We don’t just want to look at the technology in isolation,” Gribben said. “What we want to do is look at it as a part of an operational concept.”
Marc Whedbe, director of U.S. military sales for Remote Diagnostic Technologies, visited Camp Pendleton during the testing to work with MCWL and the Field Medical Training Battalion corpsmen to demonstrate the Tempus Pro’s capabilities and discuss possible improvements.
While those testing the CE marked machine are expert corpsmen who have experienced the medical demands of highly kinetic battlefields, Whedbe said anyone can operate it.
The Tempus Pro is one of the most complex and capable medical devices available to the military, and it is equally as durable, according to Gribben. The military specifications on the Tempus Pro require it to withstand 26 drops from all acute angles, 10 to 15 minutes under a fire hose, and ball bearings dropped from four feet onto the screen.
The Tempus Pro features a daylight readable display, long battery life, intuitive interface and a glove-friendly touch screen that enables ease of use for both advanced and basic life support paramedics and emergency practitioners.
Its ability to document and share all patient data electronically ensures that all care providers have accurate information on patient injuries, therapies, trending vital signs, drugs and fluids that can be handed over, or sent ahead via ReachBak, ahead of the patient arriving at a hospital or next level of care, the company notes.
The platform is designed to be scalable to accommodate immediate and evolving needs and budgets, with the ability to add advanced capabilities post-purchase. This will enable users to perform various diagnostic processes on patients using the same battery and display already being carried. This flexibility and scalability enables users to leverage the most from their pre-hospital/transport monitor investment.
The U.S. Food and Drug Administration-cleared telemedicine device from Remote Diagnostic Technologies Limited underwent two days of informational and operational testing in Camp Pendleton, Calif., earlier this year. The Tempus Pro attaches to the patient at the point of injury and broadcasts vital signs back to a battalion aid station or aiding physician who in turn, helps field soldiers diagnose and treat battlefield injuries.
Lt. Cmdr. David Gribben, project head of expeditionary medicine with Marine Corps War Fighting Lab (MCWL), said the brief field trial allowed military officials to test the device in a controlled setting to determine future options for the product.
“We don’t just want to look at the technology in isolation,” Gribben said. “What we want to do is look at it as a part of an operational concept.”
Marc Whedbe, director of U.S. military sales for Remote Diagnostic Technologies, visited Camp Pendleton during the testing to work with MCWL and the Field Medical Training Battalion corpsmen to demonstrate the Tempus Pro’s capabilities and discuss possible improvements.
While those testing the CE marked machine are expert corpsmen who have experienced the medical demands of highly kinetic battlefields, Whedbe said anyone can operate it.
The Tempus Pro is one of the most complex and capable medical devices available to the military, and it is equally as durable, according to Gribben. The military specifications on the Tempus Pro require it to withstand 26 drops from all acute angles, 10 to 15 minutes under a fire hose, and ball bearings dropped from four feet onto the screen.
The Tempus Pro features a daylight readable display, long battery life, intuitive interface and a glove-friendly touch screen that enables ease of use for both advanced and basic life support paramedics and emergency practitioners.
Its ability to document and share all patient data electronically ensures that all care providers have accurate information on patient injuries, therapies, trending vital signs, drugs and fluids that can be handed over, or sent ahead via ReachBak, ahead of the patient arriving at a hospital or next level of care, the company notes.
The platform is designed to be scalable to accommodate immediate and evolving needs and budgets, with the ability to add advanced capabilities post-purchase. This will enable users to perform various diagnostic processes on patients using the same battery and display already being carried. This flexibility and scalability enables users to leverage the most from their pre-hospital/transport monitor investment.